Effect of esketamine and etomidate anesthesia on neuroplasticity in electroconvulsive therapy for treatment-resistant depression.
World J Psychiatry September 19, 2025 DOI: 10.5498/wjp.v15.i9.109458 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Patients with treatment-resistant depression undergoing electroconvulsive therapy |
| Interventions | Esketamine Etomidate |
| Topics | Depression Esketamine Neuroplasticity |
| Key findings | Esketamine anesthesia increased neuroplasticity markers (e.g., BDNF) compared to etomidate during ECT for treatment-resistant depression. |
Abstract
Effect of esketamine and etomidate anesthesia on neuroplasticity in electroconvulsive therapy for treatment-resistant depression.